Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Operating Cash Flow Growth
-30.78%
Quarterly · Period ending:
LCTX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.78%period ending
Latest reported-30.78%period ending
LCTX Quarterly Cash from Operations YoY % (-300.00% → -30.78%)
Year-over-year change
High-resolution chart · PNG
LCTX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 34.8145% | |
| 36.6774% | |
| 33.7034% | |
| -132.2878% | |
| 11.4864% | |
| -33.1605% | |
| 58.3333% | |
| -40% | |
| 0% | |
| -20% | |
| -300% | |
| -71.4286% | |
| -140% | |
| -66.6667% | |
| 0% | |
| -20% | |
| 33.3333% | |
| -66.6667% | |
| -50% | |
| -66.6667% | |
| -50% | |
| 0% | |
| -33.3333% | |
| 0% | |
| -300% |